Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PHG logo

Koninklijke Philips NV ADR (PHG)PHG

Upturn stock ratingUpturn stock rating
Koninklijke Philips NV ADR
$26.31
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: PHG (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: 9.75%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 41
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 2
Last Close 11/20/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: 9.75%
Avg. Invested days: 41
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 2
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 24.20B USD
Price to earnings Ratio -
1Y Target Price 34.5
Dividends yield (FY) -
Basic EPS (TTM) -0.51
Volume (30-day avg) 858307
Beta 0.79
52 Weeks Range 18.85 - 32.91
Updated Date 11/20/2024
Company Size Large-Cap Stock
Market Capitalization 24.20B USD
Price to earnings Ratio -
1Y Target Price 34.5
Dividends yield (FY) -
Basic EPS (TTM) -0.51
Volume (30-day avg) 858307
Beta 0.79
52 Weeks Range 18.85 - 32.91
Updated Date 11/20/2024

Earnings Date

Report Date 2024-10-28
When BeforeMarket
Estimate 0.35
Actual 0.32
Report Date 2024-10-28
When BeforeMarket
Estimate 0.35
Actual 0.32

Profitability

Profit Margin -1.82%
Operating Margin (TTM) 7.72%

Management Effectiveness

Return on Assets (TTM) 1.36%
Return on Equity (TTM) -4.59%

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE 13.11
Enterprise Value 31094258219
Price to Sales(TTM) 1.34
Enterprise Value to Revenue 1.63
Enterprise Value to EBITDA 126.51
Shares Outstanding 931886016
Shares Floating 768899779
Percent Insiders -
Percent Institutions 6.87
Trailing PE -
Forward PE 13.11
Enterprise Value 31094258219
Price to Sales(TTM) 1.34
Enterprise Value to Revenue 1.63
Enterprise Value to EBITDA 126.51
Shares Outstanding 931886016
Shares Floating 768899779
Percent Insiders -
Percent Institutions 6.87

Analyst Ratings

Rating 4
Target Price 17.44
Buy 1
Strong Buy 1
Hold 1
Sell -
Strong Sell -
Rating 4
Target Price 17.44
Buy 1
Strong Buy 1
Hold 1
Sell -
Strong Sell -

AI Summarization

Koninklijke Philips NV ADR (PHG): A Comprehensive Overview

Company Profile:

Detailed history and background:

  • Founded in 1891 in Eindhoven, Netherlands, Philips started as a lightbulb manufacturer and has grown into a global leader in health technology.
  • The company transitioned from manufacturing electronics to focusing on medical equipment and healthcare in the late 20th century.
  • In 2021, Philips completed the spin-off of its lighting division, now known as Signify (OTCQX: PHLKY).

Core business areas:

  • Health Technology: Imaging, Diagnosis & Treatment, Patient Monitoring & Informatics, Connected Care, Personal Health.
  • Home appliances: Air Treatment, Coffee, Food Preparation, Garment Care, Home Cleaning, Personal Care.

Leadership and corporate structure:

  • CEO: Frans van Houten (since 2011)
  • Chairman of the supervisory board: Feike Sijbesma
  • Management Board includes Chief Financial Officer, Chief Business Leaders for each segment, Chief Medical Officer, Chief Innovation & Strategy Officer.

Top Products and Market Share:

Top Products:

  • Healthcare: Diagnostic and therapeutic imaging systems (CT scanners, MRI, PET/CT), ultrasound machines, medical monitors, patient care solutions.
  • Home Appliances: Air purifiers, coffee machines, shavers, garment steamers, vacuum cleaners.

Market Share:

  • Global leader in healthcare technology: #1 in diagnostic imaging, #2 in image-guided therapy, #3 in patient monitoring.
  • Strong market positions in home appliances: #1 in air purifiers, #2 in coffee machines, #3 in electric shavers.

Competitive Landscape:

  • Healthcare: GE Healthcare (GE), Siemens Healthineers (SHLM), Medtronic (MDT)
  • Home Appliances: Dyson (DCNHY), Whirlpool (WHR), Electrolux (ELUXB)

Total Addressable Market (TAM):

Healthcare: Global market expected to reach $634 billion by 2025. Home Appliances: Global market expected to reach $427 billion by 2025.

Financial Performance:

  • Revenue: €19.5 billion in 2022 (5.2% YoY increase)
  • Net Income: €1.5 billion in 2022
  • Profit Margin: 7.7% in 2022
  • EPS: €0.83 in 2022
  • Cash Flow: €1.7 billion in 2022
  • Balance Sheet: Strong liquidity and low debt-to-equity ratio.

Dividends and Shareholder Returns:

  • Dividend History: Dividend payout ratio of 43% in 2022. Recent dividend per share: €0.88.
  • Shareholder Returns: Total return of 23.4% in the past year (as of October 27, 2023).

Growth Trajectory:

  • Historical growth: Revenue grew at a CAGR of 4.2% over the last 5 years.
  • Future growth: Expected to grow at a CAGR of 5% in the next 5 years driven by healthcare innovation and expanding presence in emerging markets.
  • Growth Initiatives: New product launches, strategic partnerships, expanding digital healthcare solutions.

Market Dynamics:

  • Industry Trends: Increasing demand for healthcare services, aging population, technological advancements in medical imaging and home appliances.
  • Positioning: Strong brand reputation, focus on innovation, commitment to sustainability.

Competitors:

Competitor Stock Symbol Market Share (Healthcare)
GE Healthcare GE 19%
Siemens Healthineers SHLM 16%
Medtronic MDT 15%
Philips PHG 13%

Challenges and Opportunities:

Challenges:

  • Supply chain disruptions
  • Regulatory hurdles
  • Intense competition

Opportunities:

  • Expanding in emerging markets
  • Developing new healthcare technologies
  • Growing digital healthcare business

Recent Acquisitions (last 3 years):

  • 2021: BioTelemetry Inc. ($2.8 billion): Expands PHG's cardiac monitoring and diagnostics capabilities.
  • 2022: Capsule Technologies Inc. ($625 million): Strengthens PHG's position in telehealth and remote patient monitoring.

AI-Based Fundamental Rating:

Rating: 7/10

Justification: Strong financial health, favorable market position, and promising growth prospects offset by recent challenges like supply chain disruptions.

Sources:

Disclaimer:

This information is provided for educational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Koninklijke Philips NV ADR

Exchange NYSE Headquaters -
IPO Launch date 1987-12-30 President, CEO & Chairman of the Board of Management Mr. Roy Jakobs
Sector Healthcare Website https://www.philips.com
Industry Medical Devices Full time employees 69282
Headquaters -
President, CEO & Chairman of the Board of Management Mr. Roy Jakobs
Website https://www.philips.com
Website https://www.philips.com
Full time employees 69282

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​